The National Institute for Biotechnology in the Negev; Ltd.
发明人:
AHARONI, Amir,LEVIN, Itay
申请号：
EP15785490
公开号：
EP3137495A4
申请日:
2015.04.27
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
Death-domain receptor 3 (DR3) variants having increased binding affinity to TL1A, and composition comprising same, are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of autoimmune and/or inflammatory disease are provided.
